Marsh & McLennan: McGriff Acquisition Is A Good Deal
Marsh & McLennan: McGriff Acquisition Is A Good Deal Source link Lighting Rock Research
Marsh & McLennan: McGriff Acquisition Is A Good Deal Read More »
Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued (STE)
Eoneren/E+ via Getty Images I assigned a ‘Hold’ rating to Steris (NYSE:STE) in my article published in February 2024, highlighting their strong growth in Healthcare products alongside the weakness in Applied Sterilization Technologies (AST) business. I believe the company has
Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued (STE) Read More »
Adobe Q3: $550 Million In Net New ARR Growth Guidance Is Not Bad (NASDAQ:ADBE)
wwing I published my ‘Strong Buy’ thesis on Adobe Inc. (NASDAQ:ADBE) in June 2024, highlighting their strong AI positions in Firefly. Adobe released a strong Q3 result on September 12th after the bell, while they guided a weak growth in
Adobe Q3: $550 Million In Net New ARR Growth Guidance Is Not Bad (NASDAQ:ADBE) Read More »
Oracle Q1: On-Premise Offerings Remain a Concern Despite Oracle Database@AWS Launch (ORCL)
maybefalse/iStock Editorial via Getty Images I assigned a ‘Sell’ rating to Oracle (NYSE:ORCL) in my article published in January 2024, arguing that the company is losing strength in cloud and AI. Oracle released its Q1 FY25 result on September 9th